{"ticker": {"uuid": "ce563818-80d5-4f19-9b3b-26c92a0bb489", "symbol": "4503", "name": "Astellas Pharma Inc.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "FDA\u2019s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T10:31:49+00:00", "published_display": "11 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astute Medical highlights its diagnostic focus as Astellas Pharma deepens U.S. market presence", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPUkVXV3l6YktCTnQ3enhndmtsUTNoZmt6b2xXanFnblhXWXFrRFJfNDNMdlhYRUJONGlyOWxOOGM5eHRPOFNKejJSX0pnaWE3S2FRVnZRek1xVFVILW93ZHcxdVg4c0pTOERuU1VBNUxqTERycGcyTzdHckVCV0d0X3BGVURpOGh2bVNhNDBtVkJnTmM2VFM2bkEwQVg3R2NrRUxVZlNXcUNYaXZSeU5TVG5jOXdFeG12NWlnNkVCMGI0dHhoTHR2VG5vVUc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T15:02:02+00:00", "published_display": "04 Jul 2026 15:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma's (TSE:4503) Earnings May Just Be The Starting Point", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOQ3BkUzFEMWhzLW01dFd0Q3pabTFrcjVCNk9ubFdHdWx4ejFVUkFzN0ZFa0hrY2dadWV3aDNpU2JnblNkeURCRHVuRUFIVGhEX0xKTmlMNVNpWWRuYnZhc1UyV2ZSYXFHdWdjbDl3d1FOZEgxeHRoNGFqSjNVbm0tME1HdHNOSnJQYU1BUUNBcmVOWUkzZEpscVNiVEkwbHRlQTJjV1BRcw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Astellas Pharma (TSE:4503)'s Value-Focused Re\u2011Rating Means For Shareholders", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Stock Valuation After KRAS Trial Progress And AI Overhaul", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOX0tZMW5wdnpoaXpWM1NQb0JWbEY4WloxRVczUE1DNmpPdWFTNnlsTVpSV2N4aGdMejZ0amhDb1FqdWs5TGxjaFo2TklKMnkxWmZ4NUV3TUl0Z0FDZld0czZNRm5ReTZEQjBLejh4NUNjMEJ4bzllNmp2RWItajhKaldsZllNeEtCQ2s5NXdmYXRlYkg4amlKcEFYNA?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas taps AI to reshape clinical programs as rising stars emerge", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPTW5ua05zRDliY3hPaHRDN2ZvS2N4b2JXRDVYaFVDVXR2bXg3aXNSYUNLblFvUjBjTk5WWHZ1RS1GeVgyRkEySzFlQUNhQUIwSE9nYVhtV2dyS1NTZUpyVTdSMGZNaWlBT3IwV0dYNmxJS3J5TmZZa0RJSmE3VlUxNmNLb2pRZHhSZXdjOE5NTTJhLVdJanVjbUV2N2M3a2tWVGlkZw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQMF9DdVdyZDROUl91SW9ySnFncVloYUhhMHRSVXNHNGJWVDdPWURaZFlIQjJ4YVJ4OXZPWU9XNzRPMVBaeGxiTU54bFZ4eFpHSXJsdVpTMHNPaUg1Uk5TTERabFRERlVxR1dqZzBPd21pNWd2N1VEclRhbDAxNnQ5Q1FLaTRBZ08wSGtpaldiZWJTWUt2RlNVVkhBNzlrZkJNUld3TVhhSXdVNVlXYlJCYklsQkRGRUxoN1lZUlkwRkJoRFA2c3ZMTWxIalQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Board Change Raises Questions On R&D Oversight And Governance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZE1KZDhBQlZmMjlscV82U0VoY3piN2dxRlphcVV1MFg2RTAzckxqbjdHdUplMXQydUtZV0FKVE9wUzJtZ2V6clZ5VHN2azJrVjdOaWZBSVE1S29BcUhNRmFNc0dnbVpHeWhleEdrN08tbzZ1LWdOQU9HRTgyTEhIZTBmaGJoSXVtVzgwaEpOUEdja1dudVFSbzBaTkxWQXB2XzRPZDBoN1h5WFU?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Astellas Pharma stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPQzFRM25nNWhFM0ZmZHJtVVRIRG1GNDhZWkJvRk9CVUYycXR1ZTBVT2lpOTRKSWpxUzFMZEtyUkxCQXEyVjBueTdWQ0xlb1I0azJydFo2NHpUbXBxTkxLb1FsVndVTmVoUElhLTJRbXVaZ0Z1d0pLTFo4NHJ3aDFxS2REQlk0YzhSVFB0OUxhRlJ4Z3N4anMzZ0RSdGpyQ0w5NnVLaE0zNA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma Shares Fall After Unveiling Five-Year Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQM0M0M3gxZzlfSGZ3TVF0TkJtY1E4Mmh6RVZTaFZrMmtHT29HaDRRMHVFRVcwa1lMVHZ0R29fclg5eGxubjZ2bk9hamxaNEx4cHRWNXdHRTNFWHpZczhjVHhvZXZLblVyck5ZWDlSbF8tRVNtUURpamU4LWxWcFFmYXJPbFF2QkZGV2NpdGZxRXBwZ0ttQ2NiZ3hDWTJRMDhiMGNPVGRmcm5ZOWFUckE?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks (JAZZ:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMUwyTEJCdVVvX29VbHQyYzlISHVaanI4ZFRLNEhIRTRJYUVVbVoxNTFrRDNLbjcxN3RnbTRPZ0lVaTZTMUI1X1lVb2N1NWlnZFJla2dJVkExaHlLajhZYTFUYU9DanJ0V0k5eF9VeXpLZkR2TEVxUHN2d2RhRTNCQzhGX29uYzNwaW5ENFc1ek9DNmFIQWZnUU5OVU1KWmtVQWpUT3M0em0?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Margin Surge To 13.6% Tests Bearish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Astellas Pharma\u2019s Valuation After A Strong Year Of Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRDVDX2lZTEsyMVlHR0tzSHVyaWQ1bU1PRGM4TEt3cG5oQU15MFYwNnVzTnZFQnktT2lrWjlIdVUtUEdQMmhUZ1g5XzlVRTRVcllkanBnMFYyZU9iN0dqNmx0YnVsQVE3WENBS3JlS2tCLXFVcS1seGJXQ0hNOVBNUkNZUmhDdDRTMlVGQlNGWlZ3SF9oUEdwRW1xc3pWN0FKcVVkZg?oc=5", "source_name": "Market source", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Licenses Dyno Muscle Gene Therapy Capsid And Investors Weigh Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trump\u2019s Drug Cost Push Helps Astellas Win Higher Price in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQMUZBc3pnNnRnZzVWcUJkTFQ3a3JYUUM3RTItd0lSV1pXaHB5dXFsdHFoVjlxNW94cFMzRmRTd2dYZDFkWnZvMzFURkJzM1l0MUlkMnNSVkd6ZkxRdkY1MmNIdVdPZGpCWVBVTVpDdjl6RXRKMHExaVB2YlNqM0p3bUR1aGtUUlFXdjhkcklCbjdac3JBUGs4andfTFV6WjNiS3FtUHl5bEZ0UFAzRW5xNGRQVjY?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas and Vir in $1.3B deal for CD3 T-cell engager", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQemN1Ui1UMWRnNk5yZFowT2k3cnFuTlBjSVZFazdxLVdfOHhtYUk1RWF3Z2RwaC1WOGtGMHBuLVBpSFg3dXNEM1Z0bnJOOHlRM3hjMjZYT0RPMWQ3b0RieGMwc0FkSDNEb2E1MGVHYTE2V3d4VVdWNFhfSTdEQ1RibHo1alN6VGI3dlVWdlJja0lyVWl0ejJv?oc=5", "source_name": "BioWorld News", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Astellas Pharma (TSE:4503) After An 83% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNQlQzSmlIa2ZkQnFMTGd1UXpjVFpETzkyRE9iX0xaemNKX2RUeWpPMWo1OXZ4MFFodUllOEdSSWxFWlN6ZDV4aUNKMGpWRGdmRGJZRVUxdXQ4cVFJb25kVnN4OFJ3VGg2d216QlRJQXdURFZ6SFVhSVNjYmMxd2lqcDhFRTQ?oc=5", "source_name": "Market source", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's Lupin settles US patent dispute with Astellas Pharma for $90 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxORmxlTDl2VW9aenZBRFM2a3Zfdi05aUJ4RXlxY1NVM2dRV3RmS1hjSThEdTdmWGRhZFNveGkzQy1vQS1YcVloSUpCUmJYVTlOOVNGUFNqVTVXbXc3VkdvOGR3US1hOHhLOTdveFlNMm9nbTBUUlJsWGI0U040QmRJZXNueVhjVlo0eUxwclFIQWxiZDEydDJFTGctanM5QVExOFFoc2N4TXlubEpiLURaOEJCU2lURVlyWHBxa3ozRmhLelVTXzVDbTVSdDVEQmxRb2ZXMUN4Y2pRa2JuQWFOUGVBcjBGUVU?oc=5", "source_name": "Reuters", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Has Announced A Dividend Of \u00a539.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYXpRT3JtTXN5bjQtMnBvdm5kNV94UWo4TUFSUU5kQlJhZmtRVHhnc25lbHNFTEZfVDVRZFk1VE5zR3V2RkI2XzlvTHl5NnBLWmxuY3FOOTd0eWpkN2FMM0g4VEhqX0ViUFZnV0JVSjR4a0FXdE8yZXVOd1ZONl9XYVBHTTduUm51TEhZT1NVVGxmc0dsb0JzMTZSLXRRbE1vcTZwdGczemlVTThCdWswSGtpNVJBZEh1WmtlUkhYNVBITE1sOEZKNWtRRi1xZ2R3N2d6Z0JoYmpqZkduVW1MOXpvY9IB6AFBVV95cUxQNVBqU2F2QjRFS1VzYTB1R2o3T3JSMThWWVg0SnRQbGFpSU9jQUV1bGFuUE1EMkpHMXoyUUdFVlNCc3QzNGlOTmtveTM0cXp1cjVWZnpxY3p3YmV3X3ZYRHR5T0lXZkJtRUQzS1c3eU9YLVJBRERnSlQzdGJxSU1XSHdmT1VYOEh0ZHE0eVVqN1dhU2hzekptMmxKbGNCa3VOaDlaVm92cXFRUTF3Y080LWJkTV9paEwtOHIzeGRsMnpacWNSYmRJWlM3SFVtQXBoM1d3X2plZ1JoejRzVEQtelVWOXRzMzd1?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Attractive Is Astellas Pharma After a 44.1% Surge and Mixed Valuation Signals?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOLVRjd1pxWUktVjVDcFBSRDBwZ3JfUkNiYkE0bC0tYklQVlpmMVZoUWZwbk9XdTc0Wk5PVEhpbllTU2c3RkRnMkpUWXY3V2IwSmNzc0NndzhGejk0enZVM0hjak0tMURtSzkxR1NZQ1ZNVEw5Y1VqMHI0VDdZZ2Y0eFNLWQ?oc=5", "source_name": "Market source", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas\u2019 zolbetuximab misses pancreatic cancer phase II endpoint", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMWhzclFDeVRrLXRRXzBHVW9KZnVIdnUzY0ZRb2wwOF8tLUdQTm5DcFUwNG5PT3NKMzZ6ZjBJZTJETlI1SHJ2c3BaaGpfYlItZVFnMEFIWkxFUXZMRW1TZURCX3dmWFZrRU8zdjE0alQtWllpWExhRDdEcE55UGJQc041OEt0Zzk3XzN6SFVoWlp5RXhid29QTkluUExoNzZ2ZVZZUjNBcEo?oc=5", "source_name": "BioWorld News", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Astellas says employee indicted by China's prosecutors", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNajc5QXJIQi1qR2pkVV9CbWFyc2hjRk1yaHpjN0dfYURwY05JMFNRZGVoRTFxVU5fcTM3UXhCaTJSNU9nRWFtOWtPS1pIOGYwbVRXWGhiUDI4LWVWOUdxSFY5MG1BTlVvYmktWjUtcmtzbmVwNzBELW1feWtLeGlVUnhEREhHUF9XU1J5azFMNFJtblNjbUJ3Z043MXY1NzlSNlVGblh4VEwtTE9vRzdQS09kVDk4bVJ6MFVPbjNXcXNLa01vbEV4M3FKdDQ?oc=5", "source_name": "Reuters", "published_at": "2024-08-21T07:00:00+00:00", "published_display": "21 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas India MD On Action-Packed Run Ahead, Breaking The Glass Ceiling", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPLWo2QkZRQU5HMHc3R1RrMlRtcm1SNW4tUDVzOVk0V2ZLNHpiOG9JN2NLcXFiMUhFbk8xV3VCT0VOTHYzWFdzeTlBeWl3ek1paU1UbXZ2X0ZNUlo0OHF0bDZGTmtYSEJoNUlzSjJEbVJWTTNFcnlSbVZiQ2JzcEMtekRYRXlhelpXRFJuS243TDE2d2VBbjhfQ2trendySGtDamxtM0gwdG5SekstQXRB?oc=5", "source_name": "insights.citeline.com", "published_at": "2023-11-27T08:00:00+00:00", "published_display": "27 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BREAKING NEWS: Astellas reaches agreement to acquire Iveric Bio for $5.9 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQUXpIV2NuRnJpRDZtLTJlMXlrcmc4VVFSTVNHckw0bGtoWVluWXU5MDRCTEdUXzNhbVRiWXAyS25UUTc2dWVsRnNHblJvVHNZUDdJbThJRzhaTENlUnF3a2FOdFdBLWhFMjBWZDJWQjE1MVV2SlJJbzVkSzdvTzdzNkx5a25iR3gwR1VINmtKQkxuSjhzbmU5Skg0dHJ4bVdFWG43OFNsdjlQcFhveWlpbDRkVDFtUkQ5ZFE?oc=5", "source_name": "Ophthalmology Times Europe", "published_at": "2023-05-01T07:00:00+00:00", "published_display": "01 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Completes Acquisition of Audentes Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSkU1aEVxaVctcHBOLVZRUnppV3d2V3pTTU1xQ3RuVWRmclNTVkxHcW53VW14TDBDMkFBdWt0a3E5Y0cyel85c3VNMnA0TFJZbGxGQWxXcmFjdTVxRERQQWw3THBGZlVQUldmY1ZlLVQ0RmlmZkJqSGQ2OGI4S1lnVXBCNUhkNFlkZ1Zmejk1R1BtYlkzUjVoa0JsaGozT01pSV9RTjRFdkFrRkRWQTd0Sg?oc=5", "source_name": "PR Newswire", "published_at": "2020-01-15T08:00:00+00:00", "published_display": "15 Jan 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Acquires Potenza Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPVTdSN1J4cXVPYzZ2cm56Ulg5N2wzWFYxWjM4RlFDT01oc3pscDdST0lnVV8zWFVOcTRJSVM5OWJJRlcxSU4wbWhxbEhnVzVILWM4cjEtaDhJSVdZUzhHaFQ5NW9NanJnQUNFNFhYSW5UNlJtYW1UVk9GVENHbk9haVFEaGxyMXZBMno3d3BBTW5LNUpVYmZGR2NB?oc=5", "source_name": "PR Newswire", "published_at": "2018-12-14T08:00:00+00:00", "published_display": "14 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas to Acquire Ganymed Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNMDI1aGhSejZ2Q2ljWHFBS3FsOWMtZTZEZU9GaV9iS1Z6T0VnWHB6dGlleDk1UFZyNXRnalF4NlZWRzJWSzIyMlVkWEUyUzZIYVozTlFrYlhldDFOX3dOOWlVQnRrdlgzQW1fZDRCMTJZVHZqS1lrRWsyYmZmb2U1WjVfZWpkTXVMRXpoRXZzYUk5SlJ2cFNIellIUTNxYnBF?oc=5", "source_name": "PR Newswire", "published_at": "2016-10-28T07:00:00+00:00", "published_display": "28 Oct 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas to Acquire Ocata Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOd2FLR3p0U0dCTkp1M2Z3cFFuSER4MF9jbjRQSlhfdU9ZZUZ3Q3F1WkZkaEJJdF9FLS1lcTFJMEJqMFNhUkw5RGZYdXNReE1IUkRTbTdhZG4zUjBJZmUwU0ZFazJuMzhiVHBfUmc0VlBuSDdKcjcwT3NncEd6eERaNkhNTTFNRGh6T1JrdWduNU9MeG50Rko5ei13?oc=5", "source_name": "PR Newswire", "published_at": "2015-11-09T08:00:00+00:00", "published_display": "09 Nov 2015 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "FDA\u2019s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T10:31:49+00:00", "published_display": "11 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astute Medical highlights its diagnostic focus as Astellas Pharma deepens U.S. market presence", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPUkVXV3l6YktCTnQ3enhndmtsUTNoZmt6b2xXanFnblhXWXFrRFJfNDNMdlhYRUJONGlyOWxOOGM5eHRPOFNKejJSX0pnaWE3S2FRVnZRek1xVFVILW93ZHcxdVg4c0pTOERuU1VBNUxqTERycGcyTzdHckVCV0d0X3BGVURpOGh2bVNhNDBtVkJnTmM2VFM2bkEwQVg3R2NrRUxVZlNXcUNYaXZSeU5TVG5jOXdFeG12NWlnNkVCMGI0dHhoTHR2VG5vVUc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T15:02:02+00:00", "published_display": "04 Jul 2026 15:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma's (TSE:4503) Earnings May Just Be The Starting Point", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOQ3BkUzFEMWhzLW01dFd0Q3pabTFrcjVCNk9ubFdHdWx4ejFVUkFzN0ZFa0hrY2dadWV3aDNpU2JnblNkeURCRHVuRUFIVGhEX0xKTmlMNVNpWWRuYnZhc1UyV2ZSYXFHdWdjbDl3d1FOZEgxeHRoNGFqSjNVbm0tME1HdHNOSnJQYU1BUUNBcmVOWUkzZEpscVNiVEkwbHRlQTJjV1BRcw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Astellas Pharma (TSE:4503)'s Value-Focused Re\u2011Rating Means For Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQXzgwSk1CR2xFOEd4VkZNYmRHc29IVFFIZ2VRRGRjb2NuWWxQdnRqY0o0RFZFSTNXbmJzV0plTXVpNkNReXpuMjQ1ZnRMekNQYzFlWTFqZWJmQVc2UTBKeEttVnRWWlBZQ3JNU3lpT0JWN1h6NnMzSXpDOG1saDJOdUx0S1JVTHZQZzBBZnRQYlBpZFM4b1B3ZndKV20xdUZwY3c3WHBxYkhwaUlwN2gwTnJNSEk5OFd1ZFdHcTBIMkpWN3dHUVJURXVKcW9SQi1qYjlncEJ5Z3kxczVxN1NDellXVjdSeTV00gHuAUFVX3lxTE10U3YyT3B5OFF6SlFOVXlXTzNPVDFoZnNJU3ZzU2V2aXlhNWpVbzBVYW1XNGhKN0xMTTJCZERxSVppRXk4emQtRUdoUTgyOGtMSDlncmhDbXN4UzhYWU9Hd1c0ZjhRb2poM3JBSGN2MjJuM0V5TmpNR2NpUURGMkNvMzk3Y1FQaXFvbFNWcEU4NXpvbkZ0bzJITy1pRHpZWkl2QlU5U2k4ZGpwcGNPVnYyZUU0WXdWVDZDY1h4YmR6LVRYWGUza0xiTUY4S0p0OW5hdnRQdUxrbUU4THNNNFpDY2F0Z01NSHdWblNnQUE?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Stock Valuation After KRAS Trial Progress And AI Overhaul", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOX0tZMW5wdnpoaXpWM1NQb0JWbEY4WloxRVczUE1DNmpPdWFTNnlsTVpSV2N4aGdMejZ0amhDb1FqdWs5TGxjaFo2TklKMnkxWmZ4NUV3TUl0Z0FDZld0czZNRm5ReTZEQjBLejh4NUNjMEJ4bzllNmp2RWItajhKaldsZllNeEtCQ2s5NXdmYXRlYkg4amlKcEFYNA?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas taps AI to reshape clinical programs as rising stars emerge", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPTW5ua05zRDliY3hPaHRDN2ZvS2N4b2JXRDVYaFVDVXR2bXg3aXNSYUNLblFvUjBjTk5WWHZ1RS1GeVgyRkEySzFlQUNhQUIwSE9nYVhtV2dyS1NTZUpyVTdSMGZNaWlBT3IwV0dYNmxJS3J5TmZZa0RJSmE3VlUxNmNLb2pRZHhSZXdjOE5NTTJhLVdJanVjbUV2N2M3a2tWVGlkZw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQMF9DdVdyZDROUl91SW9ySnFncVloYUhhMHRSVXNHNGJWVDdPWURaZFlIQjJ4YVJ4OXZPWU9XNzRPMVBaeGxiTU54bFZ4eFpHSXJsdVpTMHNPaUg1Uk5TTERabFRERlVxR1dqZzBPd21pNWd2N1VEclRhbDAxNnQ5Q1FLaTRBZ08wSGtpaldiZWJTWUt2RlNVVkhBNzlrZkJNUld3TVhhSXdVNVlXYlJCYklsQkRGRUxoN1lZUlkwRkJoRFA2c3ZMTWxIalQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Board Change Raises Questions On R&D Oversight And Governance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZE1KZDhBQlZmMjlscV82U0VoY3piN2dxRlphcVV1MFg2RTAzckxqbjdHdUplMXQydUtZV0FKVE9wUzJtZ2V6clZ5VHN2azJrVjdOaWZBSVE1S29BcUhNRmFNc0dnbVpHeWhleEdrN08tbzZ1LWdOQU9HRTgyTEhIZTBmaGJoSXVtVzgwaEpOUEdja1dudVFSbzBaTkxWQXB2XzRPZDBoN1h5WFU?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Astellas Pharma stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPQzFRM25nNWhFM0ZmZHJtVVRIRG1GNDhZWkJvRk9CVUYycXR1ZTBVT2lpOTRKSWpxUzFMZEtyUkxCQXEyVjBueTdWQ0xlb1I0azJydFo2NHpUbXBxTkxLb1FsVndVTmVoUElhLTJRbXVaZ0Z1d0pLTFo4NHJ3aDFxS2REQlk0YzhSVFB0OUxhRlJ4Z3N4anMzZ0RSdGpyQ0w5NnVLaE0zNA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma Shares Fall After Unveiling Five-Year Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQM0M0M3gxZzlfSGZ3TVF0TkJtY1E4Mmh6RVZTaFZrMmtHT29HaDRRMHVFRVcwa1lMVHZ0R29fclg5eGxubjZ2bk9hamxaNEx4cHRWNXdHRTNFWHpZczhjVHhvZXZLblVyck5ZWDlSbF8tRVNtUURpamU4LWxWcFFmYXJPbFF2QkZGV2NpdGZxRXBwZ0ttQ2NiZ3hDWTJRMDhiMGNPVGRmcm5ZOWFUckE?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks (JAZZ:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMUwyTEJCdVVvX29VbHQyYzlISHVaanI4ZFRLNEhIRTRJYUVVbVoxNTFrRDNLbjcxN3RnbTRPZ0lVaTZTMUI1X1lVb2N1NWlnZFJla2dJVkExaHlLajhZYTFUYU9DanJ0V0k5eF9VeXpLZkR2TEVxUHN2d2RhRTNCQzhGX29uYzNwaW5ENFc1ek9DNmFIQWZnUU5OVU1KWmtVQWpUT3M0em0?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Margin Surge To 13.6% Tests Bearish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Astellas Pharma\u2019s Valuation After A Strong Year Of Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRDVDX2lZTEsyMVlHR0tzSHVyaWQ1bU1PRGM4TEt3cG5oQU15MFYwNnVzTnZFQnktT2lrWjlIdVUtUEdQMmhUZ1g5XzlVRTRVcllkanBnMFYyZU9iN0dqNmx0YnVsQVE3WENBS3JlS2tCLXFVcS1seGJXQ0hNOVBNUkNZUmhDdDRTMlVGQlNGWlZ3SF9oUEdwRW1xc3pWN0FKcVVkZg?oc=5", "source_name": "Market source", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Licenses Dyno Muscle Gene Therapy Capsid And Investors Weigh Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trump\u2019s Drug Cost Push Helps Astellas Win Higher Price in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQMUZBc3pnNnRnZzVWcUJkTFQ3a3JYUUM3RTItd0lSV1pXaHB5dXFsdHFoVjlxNW94cFMzRmRTd2dYZDFkWnZvMzFURkJzM1l0MUlkMnNSVkd6ZkxRdkY1MmNIdVdPZGpCWVBVTVpDdjl6RXRKMHExaVB2YlNqM0p3bUR1aGtUUlFXdjhkcklCbjdac3JBUGs4andfTFV6WjNiS3FtUHl5bEZ0UFAzRW5xNGRQVjY?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas and Vir in $1.3B deal for CD3 T-cell engager", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQemN1Ui1UMWRnNk5yZFowT2k3cnFuTlBjSVZFazdxLVdfOHhtYUk1RWF3Z2RwaC1WOGtGMHBuLVBpSFg3dXNEM1Z0bnJOOHlRM3hjMjZYT0RPMWQ3b0RieGMwc0FkSDNEb2E1MGVHYTE2V3d4VVdWNFhfSTdEQ1RibHo1alN6VGI3dlVWdlJja0lyVWl0ejJv?oc=5", "source_name": "BioWorld News", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Astellas Pharma (TSE:4503) After An 83% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNQlQzSmlIa2ZkQnFMTGd1UXpjVFpETzkyRE9iX0xaemNKX2RUeWpPMWo1OXZ4MFFodUllOEdSSWxFWlN6ZDV4aUNKMGpWRGdmRGJZRVUxdXQ4cVFJb25kVnN4OFJ3VGg2d216QlRJQXdURFZ6SFVhSVNjYmMxd2lqcDhFRTQ?oc=5", "source_name": "Market source", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's Lupin settles US patent dispute with Astellas Pharma for $90 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxORmxlTDl2VW9aenZBRFM2a3Zfdi05aUJ4RXlxY1NVM2dRV3RmS1hjSThEdTdmWGRhZFNveGkzQy1vQS1YcVloSUpCUmJYVTlOOVNGUFNqVTVXbXc3VkdvOGR3US1hOHhLOTdveFlNMm9nbTBUUlJsWGI0U040QmRJZXNueVhjVlo0eUxwclFIQWxiZDEydDJFTGctanM5QVExOFFoc2N4TXlubEpiLURaOEJCU2lURVlyWHBxa3ozRmhLelVTXzVDbTVSdDVEQmxRb2ZXMUN4Y2pRa2JuQWFOUGVBcjBGUVU?oc=5", "source_name": "Reuters", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Pharma (TSE:4503) Has Announced A Dividend Of \u00a539.00", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Attractive Is Astellas Pharma After a 44.1% Surge and Mixed Valuation Signals?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOLVRjd1pxWUktVjVDcFBSRDBwZ3JfUkNiYkE0bC0tYklQVlpmMVZoUWZwbk9XdTc0Wk5PVEhpbllTU2c3RkRnMkpUWXY3V2IwSmNzc0NndzhGejk0enZVM0hjak0tMURtSzkxR1NZQ1ZNVEw5Y1VqMHI0VDdZZ2Y0eFNLWQ?oc=5", "source_name": "Market source", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas\u2019 zolbetuximab misses pancreatic cancer phase II endpoint", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMWhzclFDeVRrLXRRXzBHVW9KZnVIdnUzY0ZRb2wwOF8tLUdQTm5DcFUwNG5PT3NKMzZ6ZjBJZTJETlI1SHJ2c3BaaGpfYlItZVFnMEFIWkxFUXZMRW1TZURCX3dmWFZrRU8zdjE0alQtWllpWExhRDdEcE55UGJQc041OEt0Zzk3XzN6SFVoWlp5RXhid29QTkluUExoNzZ2ZVZZUjNBcEo?oc=5", "source_name": "BioWorld News", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Astellas says employee indicted by China's prosecutors", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNajc5QXJIQi1qR2pkVV9CbWFyc2hjRk1yaHpjN0dfYURwY05JMFNRZGVoRTFxVU5fcTM3UXhCaTJSNU9nRWFtOWtPS1pIOGYwbVRXWGhiUDI4LWVWOUdxSFY5MG1BTlVvYmktWjUtcmtzbmVwNzBELW1feWtLeGlVUnhEREhHUF9XU1J5azFMNFJtblNjbUJ3Z043MXY1NzlSNlVGblh4VEwtTE9vRzdQS09kVDk4bVJ6MFVPbjNXcXNLa01vbEV4M3FKdDQ?oc=5", "source_name": "Reuters", "published_at": "2024-08-21T07:00:00+00:00", "published_display": "21 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas India MD On Action-Packed Run Ahead, Breaking The Glass Ceiling", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPLWo2QkZRQU5HMHc3R1RrMlRtcm1SNW4tUDVzOVk0V2ZLNHpiOG9JN2NLcXFiMUhFbk8xV3VCT0VOTHYzWFdzeTlBeWl3ek1paU1UbXZ2X0ZNUlo0OHF0bDZGTmtYSEJoNUlzSjJEbVJWTTNFcnlSbVZiQ2JzcEMtekRYRXlhelpXRFJuS243TDE2d2VBbjhfQ2trendySGtDamxtM0gwdG5SekstQXRB?oc=5", "source_name": "insights.citeline.com", "published_at": "2023-11-27T08:00:00+00:00", "published_display": "27 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BREAKING NEWS: Astellas reaches agreement to acquire Iveric Bio for $5.9 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQUXpIV2NuRnJpRDZtLTJlMXlrcmc4VVFSTVNHckw0bGtoWVluWXU5MDRCTEdUXzNhbVRiWXAyS25UUTc2dWVsRnNHblJvVHNZUDdJbThJRzhaTENlUnF3a2FOdFdBLWhFMjBWZDJWQjE1MVV2SlJJbzVkSzdvTzdzNkx5a25iR3gwR1VINmtKQkxuSjhzbmU5Skg0dHJ4bVdFWG43OFNsdjlQcFhveWlpbDRkVDFtUkQ5ZFE?oc=5", "source_name": "Ophthalmology Times Europe", "published_at": "2023-05-01T07:00:00+00:00", "published_display": "01 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Completes Acquisition of Audentes Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSkU1aEVxaVctcHBOLVZRUnppV3d2V3pTTU1xQ3RuVWRmclNTVkxHcW53VW14TDBDMkFBdWt0a3E5Y0cyel85c3VNMnA0TFJZbGxGQWxXcmFjdTVxRERQQWw3THBGZlVQUldmY1ZlLVQ0RmlmZkJqSGQ2OGI4S1lnVXBCNUhkNFlkZ1Zmejk1R1BtYlkzUjVoa0JsaGozT01pSV9RTjRFdkFrRkRWQTd0Sg?oc=5", "source_name": "PR Newswire", "published_at": "2020-01-15T08:00:00+00:00", "published_display": "15 Jan 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas Acquires Potenza Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPVTdSN1J4cXVPYzZ2cm56Ulg5N2wzWFYxWjM4RlFDT01oc3pscDdST0lnVV8zWFVOcTRJSVM5OWJJRlcxSU4wbWhxbEhnVzVILWM4cjEtaDhJSVdZUzhHaFQ5NW9NanJnQUNFNFhYSW5UNlJtYW1UVk9GVENHbk9haVFEaGxyMXZBMno3d3BBTW5LNUpVYmZGR2NB?oc=5", "source_name": "PR Newswire", "published_at": "2018-12-14T08:00:00+00:00", "published_display": "14 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas to Acquire Ganymed Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNMDI1aGhSejZ2Q2ljWHFBS3FsOWMtZTZEZU9GaV9iS1Z6T0VnWHB6dGlleDk1UFZyNXRnalF4NlZWRzJWSzIyMlVkWEUyUzZIYVozTlFrYlhldDFOX3dOOWlVQnRrdlgzQW1fZDRCMTJZVHZqS1lrRWsyYmZmb2U1WjVfZWpkTXVMRXpoRXZzYUk5SlJ2cFNIellIUTNxYnBF?oc=5", "source_name": "PR Newswire", "published_at": "2016-10-28T07:00:00+00:00", "published_display": "28 Oct 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astellas to Acquire Ocata Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOd2FLR3p0U0dCTkp1M2Z3cFFuSER4MF9jbjRQSlhfdU9ZZUZ3Q3F1WkZkaEJJdF9FLS1lcTFJMEJqMFNhUkw5RGZYdXNReE1IUkRTbTdhZG4zUjBJZmUwU0ZFazJuMzhiVHBfUmc0VlBuSDdKcjcwT3NncEd6eERaNkhNTTFNRGh6T1JrdWduNU9MeG50Rko5ei13?oc=5", "source_name": "PR Newswire", "published_at": "2015-11-09T08:00:00+00:00", "published_display": "09 Nov 2015 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 29, "sentiment_summary": {"positive": 5, "negative": 2, "neutral": 22, "score": 51, "total": 29, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 14.2, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 2142.0, "latest_week": "2026-07-10", "one_week_move": -0.5, "four_week_move": 0.1, "twelve_week_move": -16.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.120649, "market_dynamics_buy_signal": false, "relative_strength": -18.028, "fair_value_gap": 26.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.5012, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.5% over one week, +0.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "simplywall.st", "count": 6}, {"label": "PR Newswire", "count": 4}, {"label": "Seeking Alpha", "count": 2}, {"label": "Bloomberg.com", "count": 2}, {"label": "BioWorld News", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 29}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "29", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.5% over one week, +0.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "FDA\u2019s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)"}], "updated_at": "2026-07-17T08:43:03.348972+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}